Preeti Manavalan, MD, MSc
Assistant Professor
Department:
MD-INFECTIOUS DISEASES
Business Phone:
(352) 294-5481
Business Email:
preeti.manavalan@medicine.ufl.edu
About Preeti Manavalan
Dr. Manavalan is an Assistant Professor of Medicine within the Division of Infectious Diseases & Global Medicine. She completed her medical training at Howard University College of Medicine and her Internal Medicine residency training at Yale University. She stayed on as a Chief Resident at Yale and then worked as a primary care physician and clinician educator prior to pursuing infectious diseases training. She completed her Infectious Diseases Fellowship at Duke University. While at Duke she was selected as a Fogarty Global Health Fellow and completed a Master of Science in Global Health.
Dr. Manavalan is the lead investigator of several studies including an NIH-funded K23 Mentored Career Development Award that investigates using implementation science to improve mental health and HIV care in Florida, and is mPI of a Fogarty International Center-funded R21 that seeks to improve cardiovascular disease care among people living with HIV in Tanzania. Dr. Manavalan also serves as the Associate Director of the Southern HIV Alcohol Research Center (SHARC – sharc-research.org), one of five NIAAA-funded national consortias for HIV and alcohol research that seeks to improve health outcomes and reduce HIV transmission among diverse populations. Her clinical interests include HIV, HIV-related chronic diseases, and global health.
Accomplishments
Research Scholars Program in HIV Awardee
2021
·
Gilead Research Scholars Program
Fogarty Global Health Fellow
2018-2020
·
NIH Fogarty International Center (FIC)
Interdisciplinary Research Training Program in AIDS grant recipient
2017-2020
·
NIH National Institute of Allergy and Infectious Diseases (NIAID)
Member
2010
·
Alpha Omega Alpha Medical Honor Society
Teaching Profile
Courses Taught
2025
BMS6812 Introduction to Clinical Medicine 1B
Board Certifications
-
Infectious DiseasesAmerican Board of Internal Medicine
-
Internal MedicineAmerican Board of Internal Medicine
Clinical Profile
Specialties
- Infectious Disease
Areas of Interest
- HIV/AIDS
- Preventive Health Care
Research Profile
Open Researcher and Contributor ID (ORCID)
0000-0001-7587-224X
Areas of Interest
- Cardiovascular Disease
- Global Health
- HIV
- Implementation Science
- Mental Health
Publications
Academic Articles
2025
Acceptability of Multilevel Sexual Health Interventions and Sexually Transmitted Infection Screening and Testing Among Persons With HIV Across Three Clinical Sites in Florida
JAIDS Journal of Acquired Immune Deficiency Syndromes.
98(3):282-290
[DOI] 10.1097/qai.0000000000003569.
2025
Who could benefit the most from long-acting antiretroviral therapy? perspectives of HIV care providers and people with HIV in Florida
AIDS Care.
37(7):1150-1159
[DOI] 10.1080/09540121.2025.2510915.
[PMID] 40437689.
2024
Community Health Worker Optimization of Antihypertensive Care in HIV (COACH): Study protocol for a pilot trial of an intervention to improve hypertension care among Tanzanians with HIV
PLOS ONE.
19(12)
[DOI] 10.1371/journal.pone.0315027.
[PMID] 39689146.
2024
Comorbidity Burden and Health Care Utilization by Substance use Disorder Patterns among People with HIV in Florida.
AIDS and behavior.
28(7):2286-2295
[DOI] 10.1007/s10461-024-04325-y.
[PMID] 38551720.
2024
Depression and Anxiety Symptoms and Treatment Utilization, and Associated HIV Outcomes among Adults with HIV in Rural Florida
AIDS and Behavior.
28(1):164-173
[DOI] 10.1007/s10461-023-04147-4.
[PMID] 37566153.
2024
Measuring internalized health-related stigma across health conditions: development and validation of the I-HEARTS Scale.
BMC medicine.
22(1)
[DOI] 10.1186/s12916-024-03661-z.
[PMID] 39379928.
2024
Perspectives Among Health Care Providers and People with HIV on the Implementation of Long-Acting Injectable Cabotegravir/Rilpivirine for Antiretroviral Therapy in Florida
AIDS Patient Care and STDs.
38(6):275-285
[DOI] 10.1089/apc.2024.0067.
[PMID] 38686517.
2024
Predictors of prior HIV testing and acceptance of a community-based HIV test offer among male bar patrons in northern Tanzania.
PLOS global public health.
4(2)
[DOI] 10.1371/journal.pgph.0002946.
[PMID] 38408037.
2024
Subarachnoid Neurocysticercosis Case Series Reveals a Significant Delay in Diagnosis-Requiring a High Index of Suspicion Among Those at Risk.
Open forum infectious diseases.
11(5)
[DOI] 10.1093/ofid/ofae176.
[PMID] 38680612.
2023
Hypertension in an Emergency Department Population in Moshi, Tanzania; A Qualitative Study of Barriers to Hypertension Control.
PloS one.
18(1)
[DOI] 10.1371/journal.pone.0279377.
[PMID] 36608026.
2023
Mental health, substance use, and risky sexual behaviors among women living with HIV.
Journal of nursing scholarship : an official publication of Sigma Theta Tau International Honor Society of Nursing.
55(3):751-760
[DOI] 10.1111/jnu.12900.
[PMID] 37132071.
2023
Six month incidence of major adverse cardiovascular events among adults with HIV in northern Tanzania: a prospective observational study.
BMJ open.
13(11)
[DOI] 10.1136/bmjopen-2023-075275.
[PMID] 37984949.
2023
Six-month incidence of hypertension and diabetes among adults with HIV in Tanzania: A prospective cohort study
PLOS Global Public Health.
3(8)
[DOI] 10.1371/journal.pgph.0001929.
[PMID] 37603550.
2022
A community health worker delivered intervention to address hypertension among adults engaged in HIV care in northern Tanzania: Outcomes from a pilot feasibility study
The Journal of Clinical Hypertension.
24(8):1095-1104
[DOI] 10.1111/jch.14518.
[PMID] 35899325.
2022
Hypertension among adults enrolled in HIV care in northern Tanzania: comorbidities, cardiovascular risk, and knowledge, attitudes and practices.
The Pan African medical journal.
41
[DOI] 10.11604/pamj.2022.41.285.26952.
[PMID] 35855029.
2022
Prevalence and predictors of uncontrolled hypertension, diabetes, and obesity among adults with HIV in northern Tanzania.
Global public health.
17(12):3747-3759
[DOI] 10.1080/17441692.2022.2049344.
[PMID] 35282776.
2021
Hypertension Care for People With HIV in Tanzania: Provider Perspectives and Opportunities for Improvement
Journal of the International Association of Providers of AIDS Care (JIAPAC).
20
[DOI] 10.1177/23259582211052399.
[PMID] 34751055.
2021
Increasing the Uptake of HIV Testing among Men in Tanzania: A Novel Intervention for Bar Patrons
AIDS and Behavior.
[DOI] 10.1007/s10461-020-03131-6.
2020
Hypertension burden and challenges across the hypertension treatment cascade among adults enrolled in HIV care in northern Tanzania
The Journal of Clinical Hypertension.
22(8):1518-1522
[DOI] 10.1111/jch.13929.
[PMID] 32652868.
2020
Provider-perceived barriers to diagnosis and treatment of acute coronary syndrome in Tanzania: a qualitative study.
International health.
12(2):148-154
[DOI] 10.1093/inthealth/ihz061.
[PMID] 31329876.
2020
“It’s because I think too much”: Perspectives and experiences of adults with hypertension engaged in HIV care in northern Tanzania
PLOS ONE.
15(12)
[DOI] 10.1371/journal.pone.0243059.
[PMID] 33270765.
2019
Experiences of Fetal or Infant Loss among Tanzanian Women in HIV Care.
Journal of loss & trauma.
24(7):625-635
[DOI] 10.1080/15325024.2019.1600850.
[PMID] 34305478.
2019
Knowledge, attitudes, and preventative practices regarding ischemic heart disease among emergency department patients in northern Tanzania.
Public health.
175:60-67
[DOI] 10.1016/j.puhe.2019.06.017.
[PMID] 31401252.
2019
Opportunities to Leverage Telehealth Approaches Along the Hypertension Control Cascade in Sub-Saharan Africa.
Current hypertension reports.
21(10)
[DOI] 10.1007/s11906-019-0983-2.
[PMID] 31451940.
2019
Predictors of postpartum HIV care engagement for women enrolled in prevention of mother-to-child transmission (PMTCT) programs in Tanzania.
AIDS care.
31(6):687-698
[DOI] 10.1080/09540121.2018.1550248.
[PMID] 30466304.
2019
The Burden of Hypertension and Diabetes in an Emergency Department in Northern Tanzania.
Ethnicity & disease.
29(4):559-566
[DOI] 10.18865/ed.29.4.559.
[PMID] 31641323.
Grants
Jul 2023
ACTIVE
Adapting and piloting an evidence-based intervention to improve hypertension care among Tanzanians living with HIV
Role: Principal Investigator
Funding: DUKE UNIVERSITY
via FOGARTY INTERNATIONAL CENTER
Dec 2022
ACTIVE
Adaptation and implementation of a behavioral mHealth intervention to reduce anxiety and depression and end the HIV epidemic in the rural South
Role: Principal Investigator
Funding: NATL INST OF HLTH NIMH
Sep 2022
ACTIVE
Technology-based assessments and intervention to reduce alcohol consumption and improve HIV viral suppression in the Florida Cohort
Role: Co-Investigator
Funding: NATL INST OF HLTH NIAAA
Aug 2022
ACTIVE
CODUS – HIV outcome quality measure evaluation and stigma
Role: Other
Funding: FL DEPT OF HLTH
via US HLTH RESOURCES AND SERV ADMN HIV/AIDS
May 2022
– Apr 2025
mHealth technology to improve anxiety and depression care and accelerate progress on the HIV care continuum in the rural South
Role: Principal Investigator
Funding: GILEAD SCIENCES
Education
Master of Science in Global Health
2017-2019
·
Duke University
Fellowship in Infectious Disease
2016-2020
·
Duke University
Chief Resident in Internal Medicine
2013-2014
·
Yale University
Residency in Internal Medicine
2010-2013
·
Yale University
Medical Degree
2006-2010
·
Howard University
Contact Details
Phones:
- Business:
- (352) 294-5481
Emails:
- Business:
- preeti.manavalan@medicine.ufl.edu
Addresses:
- Business Mailing:
-
PO Box 100289
GAINESVILLE FL 32610